NCT01905956View on ClinicalTrials.gov

Safety and Efficacy of IQP- AK-102 in Reducing Body Weight

PHASE3CompletedINTERVENTIONAL
Enrollment

119

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Weight Loss
Interventions
DIETARY_SUPPLEMENT

IQP-AK-102

IQP-AK-102 was presented in the form of a capsule containing proprietary, patent pending combination of three soluble fibres and excipients.

DIETARY_SUPPLEMENT

Placebo

The placebo contained microcrystalline cellulose and other excepients. Both active and placebo capsules had identical physical appearance in terms of size, shape, colour and opacity.

Trial Locations (1)

10709

Barbara Grube, Berlin

Sponsors

Lead Sponsor

InQpharm Group
All Listed Sponsors
lead

InQpharm Group

INDUSTRY